| 英文名称 |
中文名称 |
CAS号 |
操作 |
| GSK621 |
6-氯-5-(2'-羟基-3'-甲氧基-[1,1'-联苯]-4-基)-3-(3-甲氧基苯基)-1H-吡咯并[3,2-D]嘧啶-2,4(3H,5H)-二酮 |
1346607-05-3 |
详细
|
| NVP-2 |
化合物NVP-2 |
1263373-43-8 |
详细
|
| Tacalcitol |
他卡西醇 |
57333-96-7 |
详细
|
| OSMI-1 |
OSMI-1 |
1681056-61-0 |
详细
|
| SU4312 |
3-[[4-(二甲基氨基)苯基]亚甲基]-1,3-二氢-2H-吲哚-2-酮 |
5812-07-7 |
详细
|
| IND24 |
4-([1,1'-biphenyl]-4-yl)-N-(6-methylpyridin-2-yl)thiazol-2-amine |
1426047-44-0 |
详细
|
| Dimethylcurcumin |
二甲基姜黄素 |
52328-98-0 |
详细
|
| DCVJ |
2-((2,3,6,7-四氢-1H,5H-吡啶并[3,2,1-ij]喹啉-9-基)亚甲基)丙二腈 |
58293-56-4 |
详细
|
| 5-HT3 antagonist-4i |
N-(3-氯-2-甲基苯基)喹喔啉-2-甲酰胺 |
930478-88-9 |
详细
|
| SC-236 |
4-(5-(4-氯苯基)-3-三氟甲基)-1H-吡唑-1-基)苯磺酰胺 |
170569-86-5 |
详细
|
| JP1302 |
N-(4-(4-甲基哌嗪-1-基)苯基)吖啶-9-胺 |
80259-18-3 |
详细
|
| LM 22A4 |
N,N',N''-三(2-羟基乙基)-1,3,5-苯三甲酰胺 |
37988-18-4 |
详细
|
| hCAIX-IN-5 |
化合物 HCAIX-IN-5 |
2451479-57-3 |
详细
|
| MQAE |
1-(2-乙氧基-2-氧代乙基)-6-甲氧基喹啉-1-鎓溴化物 |
162558-52-3 |
详细
|
| GCPII-IN-1 |
(S)-2-(3-((S)-5-氨基-1-羧基戊基)脲基)戊二酸 |
1025796-32-0 |
详细
|
| JP 1302 2HCl |
N-(4-(4-甲基哌嗪-1-基)苯基)吖啶-9-胺二盐酸盐 |
1259314-65-2 |
详细
|
| COH-SR4 |
1,3-双(3,5-二氯苯基)脲 |
73439-19-7 |
详细
|
| Piflufolastat |
化合物 T31224 |
1423758-00-2 |
详细
|
| PFI-90 |
N'-(吡啶-2-基)吡啶-2-甲酰肼 |
53995-62-3 |
详细
|
| MIP-1072 |
化合物 T24467 |
949575-20-6 |
详细
|
| 5-LOX-IN-1 |
(2-吗啉-4-苯基噻唑-5-基)(苯基)甲酮 |
55040-82-9 |
详细
|
| Y11 |
Y 11 |
1086639-59-9 |
详细
|
| NS 1619 |
1-(2-羟基-5-(三氟甲基)苯基)-5-(三氟甲基)-1H-苯并[D]咪唑-2(3H)-酮 |
153587-01-0 |
详细
|
| PKM2-IN-1 |
COMPOUND 3K |
94164-88-2 |
详细
|
| AT-13387 |
(2,4-二羟基-5-异丙基苯基)(5-((4-甲基哌嗪-1-基)甲基)异吲哚啉-2-基)甲酮 |
912999-49-6 |
详细
|
| DC260126 |
N-(4-BUTYLPHENYL)-4-FLUOROBENZENESULFONAMIDE |
346692-04-4 |
详细
|
| STF-62247 |
N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺 |
315702-99-9 |
详细
|
| FT011 |
(E)-2-(3-(3-甲氧基-4-(丙-2-炔-1-基氧基)苯基)丙烯酰胺基)苯甲酸 |
1001288-58-9 |
详细
|
| Triapine |
2-[(3-氨基吡啶-2-基)亚甲基]氨基硫脲 |
143621-35-6 |
详细
|
| SW033291 |
2-(丁基亚磺酰基)-4-苯基-6-(噻吩-2-基)噻吩并[2,3-b]吡啶-3-胺 |
459147-39-8 |
详细
|
| KRN-633 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹唑啉基)氧基]苯基]-N-丙基脲 |
286370-15-8 |
详细
|
| PFK15 (PFK-015) |
1-(4-吡啶基)-3-(2-喹啉基)-2-丙烯-1-酮 |
4382-63-2 |
详细
|
| WHI-P180 |
3-[(6,7-二甲氧基-4-喹唑啉基)氨基]苯酚 |
211555-08-7 |
详细
|
| SMI-4a |
(5Z)-5-[[3-(三氟甲基)苯基]亚甲基]-2,4-噻唑烷二酮 |
438190-29-5 |
详细
|
| Lorediplon |
LOREDIPLON |
917393-39-6 |
详细
|
| INH6 |
N-[4-(2,4,6-三甲基苯基)-2-噻唑基]苯甲酰胺 |
1001753-24-7 |
详细
|
| Telaprevir (VX-950) |
特拉匹伟 |
402957-28-2 |
详细
|
| HG106 |
ACETAMIDE, 2-CHLORO-N-[2-(4-METHOXYPHENYL)-2H-BENZOTRIAZOL-5-YL]- |
928712-10-1 |
详细
|
| AZ 191 |
DYRK1B抑制剂(AZ191) |
1594092-37-1 |
详细
|
| SGC-GAK-1 |
SGC-GAK-1 |
2226517-76-4 |
详细
|
| QNZ (EVP4593) |
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺 |
545380-34-5 |
详细
|
| TB5 |
TB5 |
948841-07-4 |
详细
|
| Tyrphostin 23 |
酪氨酸磷酸化抑制剂23 |
118409-57-7 |
详细
|
| Tetramethylcurcumin |
四甲基姜黄素 |
52328-97-9 |
详细
|
| Delavirdine mesylate |
甲磺酸地拉韦啶 |
147221-93-0 |
详细
|
| AOH1996 |
AOH1996 |
2089314-64-5 |
详细
|
| GMB-475 |
GMB-475 |
2490599-18-1 |
详细
|
| VH-298 |
VH298 |
2097381-85-4 |
详细
|
| GW 6471 |
GW 6471 |
880635-03-0 |
详细
|
| Empesertib(BAY 1161909) |
BAY1161909 |
1443763-60-7 |
详细
|
| Seltorexant |
JNJ-42847922 |
1293281-49-8 |
详细
|
| TAI-95 |
TAI-95 |
1438638-83-5 |
详细
|
| 3F8 |
化合物 T22180 |
159109-11-2 |
详细
|
| SB 747651A dihydrochloride |
SB-747651A二盐酸盐 |
1781882-72-1 |
详细
|
| Cutamesine |
1-[2-(3,4-二甲氧基苯基)乙基]-4-(3-苯基丙基)哌嗪 |
165377-43-5 |
详细
|
| 2-Thiazolecarboxamide, 5-[2,3-dichloro-4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-N-(2-hydroxy-2-methylpropyl)-4-[[(2R)-2-methyl-1-pyrrolidinyl]carbonyl]- |
|
1917306-14-9 |
详细
|
| USP1-IN-2 |
化合物 USP1-IN-2 |
2098212-05-4 |
详细
|
| Lorpucitinib |
化合物 LORPUCITINIB |
2230282-02-5 |
详细
|
| Zasocitinib |
NDI-034858 |
2272904-53-5 |
详细
|
| MAGL-IN-6 |
化合物 MAGL-IN-6 |
2414320-29-7 |
详细
|
| Dhodh-IN-16 |
化合物DHODH-IN-16 |
2511248-11-4 |
详细
|
| RM018 |
RM018 |
2641993-55-5 |
详细
|
| RMC-6291 |
(3S)-N1-[N-[[1-[4-(二甲基氨基)-4-甲基-1-氧代-2-戊炔-1-基]-4-氟-4-哌啶基]羰基]-N-甲基-L-缬氨酰基-3-[4-[(2R)-1-乙基-3-(3-羟基-2,2-二甲基丙基)-2-[2-[(1S)-1-甲氧基乙基]-3-吡啶基]-1H-吲哚-5-基]-2-吗啉基]-L-丙氨酰基]六氢-3-哒嗪甲酸(3→2)-内酯 |
2641998-63-0 |
详细
|
| RMC-6236 |
RAS-IN-2 |
2765081-21-6 |
详细
|
| PARG-IN-4 |
PARG抑制剂 |
2988890-20-4 |
详细
|
| Spiperone |
螺哌隆 |
749-02-0 |
详细
|
| Ninerafaxstat 3HCl |
化合物NINERAFAXSTAT TRIHYDROCHLORIDE |
2311824-72-1 |
详细
|
| TH-Z154 |
化合物TH-Z145 |
2260887-57-6 |
详细
|
| ZK53 |
|
3031789-26-8 |
详细
|
| WAY-659694 |
N-(4-甲基-2-氧代-2H-苯并吡喃-7-基)-4-硝基苯甲酰胺 |
867301-81-3 |
详细
|
| IGS-1.76 |
N-(苯并[d]噻唑-2-基)-3,3-二苯基丙酰胺 |
313480-47-6 |
详细
|
| RSVA 405 |
N'-(4-(二乙基氨基)-2-羟基亚苄基)异烟酰肼 |
140405-36-3 |
详细
|
| MBX4132 |
MBX4132 |
2286411-30-9 |
详细
|
| Ro3280 |
化合物Ro3280 |
1062243-51-9 |
详细
|
| RHPS 4 methosulfate |
RHPS 4 甲基硫酸盐 |
390362-78-4 |
详细
|
| DPH |
5-(3-(4-氟苯基)-1-苯基-1H-吡唑-4-基)咪唑烷-2,4-二酮 |
484049-04-9 |
详细
|
| JNJ-64619178 |
CS-2829 |
2086772-26-9 |
详细
|
| TMC-647055 |
TMC647055 |
1204416-97-6 |
详细
|
| Tie2 kinase inhibitor |
4-(6-甲氧基-2-萘)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶)-1H-咪唑 |
948557-43-5 |
详细
|
| SMS1-IN-1 |
SMS1-IN-1 |
1807943-38-9 |
详细
|
| SU11274 |
N-(3-氯苯基)-N-甲基-3-[[3,5-二甲基-4-[(4-甲基哌嗪-1-基)羰基-1H-吡咯-2-基]亚甲基]-2-氧代-2,3-二氢-1H-吲哚-5-磺酰胺 |
658084-23-2 |
详细
|
| GSK3β Inhibitor II |
4-[5-[[(3-碘苯基)甲基]硫基]-1,3,4-恶二唑-2-基]吡啶 |
478482-75-6 |
详细
|
| H7 |
1-(5-异喹啉磺酰基)-2-甲基哌嗪 |
84477-87-2 |
详细
|
| SB 215505 |
6-氯-2,3-二氢-5-甲基-N-5-喹啉基-1H-吲哚-1-甲酰胺 |
162100-15-4 |
详细
|
| CVT-6883 |
3-乙基-1-丙基-8-(1-(3-(三氟甲基)苄基)-1H-吡唑-4-基)-1H-嘌呤-2,6(3H,8H)-二酮 |
752222-83-6 |
详细
|
| CD38 inhibitor 1 |
CD38 inhibitor |
1700637-55-3 |
详细
|
| SJ-172550 |
CS-1226 |
431979-47-4 |
详细
|
| JMS-17-2 |
Pyrrolo[1,2-a]quinoxalin-4(5H)-one,5-[3-[4-(4-chlorophenyl)-1-piperidinyl]propyl]- |
1380392-05-1 |
详细
|
| MLS1547 |
5-CHLORO-7-[[4-(2-PYRIDINYL)-1-PIPERAZINYL]METHYL]-8-QUINOLINOL |
315698-36-3 |
详细
|
| SB297006 |
SB 297006 |
58816-69-6 |
详细
|
| SB505124 |
SB-505124 |
694433-59-5 |
详细
|
| CP671305 |
CS-2886 |
445295-04-5 |
详细
|
| N6022 |
N6022 |
1208315-24-5 |
详细
|
| SR4370 |
SR-4370 |
1816294-67-3 |
详细
|
| BIBF-0775 |
BIBF0775 |
334951-90-5 |
详细
|
| SR17018 |
SR17018 |
2134602-45-0 |
详细
|
| UAMC3203 |
UAMC-3203 |
2271358-64-4 |
详细
|
| GF109203X.HCl |
3-[1-[3-(二甲基氨基)丙基]-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮单盐酸盐 |
176504-36-2 |
详细
|
| AZ304 |
AZ304 |
942507-42-8 |
详细
|
| Radiprodil |
RADIPRODIL |
496054-87-6 |
详细
|